drugset / Trial / NCT04056741
Administration of Surfactant Through an Instillation Device Infasurf® (Calfactant) in Neonates- A Pilot Study
NaSingle-groupOpen-labelTreatment
Summary
A pilot study to explore and determine feasibility and safety of the administration of surfactant through a new supraglottic device in patients from 500 to 5000 grams with RDS.
Timeline
- Start
- 2025-02-07
- Primary completion
- 2025-12-12
- Completion
- 2026-03-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calfactant | Protein / enzyme biologic | 3 unknown | Other |